Combination of Cannabidiol with Taurine Synergistically Treated Periodontitis in Rats

Area of Science:

• Pharmacology
• Periodontology
• Immunology

Background:

• Cannabidiol (CBD), derived from hemp, is known for anti-inflammatory properties.
• Taurine, an endogenous amino sulfonic acid, acts as an anti-inflammatory modulator.
• The precise mechanisms of CBD's impact on periodontal inflammation require further elucidation.

Purpose of the Study:

• To investigate the therapeutic effects of CBD, taurine, and their combination on periodontal inflammation and associated inflammatory markers.
• To evaluate the impact of CBD and taurine on inflammatory cytokines (TNF-α, IL-1β), osteoclast activity (TRAP), and alveolar bone resorption in vivo.

Main Methods:

• CBD and taurine were applied to RAW264.7 cells to assess inflammatory marker expression.
• A periodontitis model was induced in Sprague-Dawley rats, followed by treatment with control, vehicle, or CBD-taurine combinations for 21 days.
• Histomorphometric analysis of rat teeth was performed to quantify alveolar bone loss and inflammatory cell infiltration.

Main Results:

• The combination of CBD and taurine significantly reduced the expression of TNF-α and IL-1β.
• Combined treatment also decreased TRAP+ cells and resorbed pit areas, indicating reduced osteoclast activity.
• In rats with P. gingivalis-induced periodontitis, CBD and taurine significantly reduced alveolar bone resorption, pocket depth, and CEJ-ABC distance.

Conclusions:

• The combination of CBD and taurine demonstrates significant anti-inflammatory and bone-protective effects in experimental periodontitis.
• This synergistic effect suggests that CBD and taurine hold promise as a novel therapeutic strategy for managing periodontal disease.